A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application.
The biocompatibility of a viscous, hydrophobic, bioerodible poly(ortho ester) (POE) intended for intraocular application was investigated. POE was evaluated as a blank carrier and as containing modulators of degradation. Each formulation was injected intracamerally and intravitreally in rabbit eyes, and clinical and histological examinations were performed postoperatively for 2 weeks. In the case of intracameral injections, polymer biocompatibility appeared to depend on the amount injected in the anterior chamber. When 50 microL was administered, the polymer degraded within 2 weeks, and clinical observations showed good biocompatibility of POE with no toxicity to the ocular tissues or increase in intraocular pressure. The injection of a larger volume, 100 microL, of POE, appeared inappropriate because of direct contact of polymeric material with the corneal endothelium, and triggered reversible edema and inflammation in the anterior chamber of the eye that regressed after a few days. After intravitreal administration, POE was well tolerated and no inflammatory reaction developed during the observation period. The polymer degraded slowly, appearing as a round whitish bubble in the vitreous cavity. The presence of modulators of degradation both improved POE biocompatibility and prolonged polymer lifetime in the eye. POE appears to be a promising biomaterial for clinical intraocular application.
Einmahl
S
S
Department of Pharmaceutical Technology and Biopharmaceutics, School of Pharmacy, University of Geneva, 1211 Geneva 4, Switzerland.
Behar-Cohen
F
F
Tabatabay
C
C
Savoldelli
M
M
D'Hermies
F
F
Chauvaud
D
D
Heller
J
J
Gurny
R
R
D000818:Animals; D001673:Biodegradation, Environmental; D005901:Glaucoma / Q000503:physiopathology / Q000601:surgery; D020327:Glaucoma Drainage Implants; D007429:Intraocular Pressure; D011108:Polymers; D011817:Rabbits; D014822:Vitreous Body
D011108:Polymers; C401107:poly(ortho ester)